Break Up the Insulin Racket

The World Health Organization considers it an essential medicine, which means it should be available “at a price the individual and the community can afford.” So why is this product increasingly too expensive for many Americans? In the United States, just three pharmaceutical giants hold patents that allow them to manufacture insulin: Eli Lilly, Sanofi and Novo Nordisk. By Kasia Lipska. (Feb. 20)
Read more: http://snapzu.com/AdelleChattre/break-up-the-insulin-racket